November 22, 2022 2:56 PM MST Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo Nov 22 (Reuters) – A one-time gene therapy for hemophilia B from Australian drugmaker CSL Ltd (CSL.AX) has been approved by the U.S. Food and Drug Administration, potentially...
